Racecadotril

Phase 2Small molecule

MMcNeil AB

Racecadotril is one of 42 small molecule programs targeting Treatment. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

TreatmentNot yet recruiting

TreatmentPreclinical

Not yet recruiting

Competition

Competitive Landscape

332 competitors in Treatment

#DrugCompanyPhaseTrials

Biltricide

Bayer

Preclinical

3 2

Racecadotril

MMcNeil AB

Phase 2

11 3

Alfenta

Jazz Pharmaceuticals

Preclinical

1 4

Niclocide

Bayer

Preclinical

1 5

Minipress

Pfizer

Preclinical

1 6

Theo-Dur

Pfizer

Preclinical

1 7

Levulan

Sun Pharmaceutical Industries, Inc.

Preclinical

1 8

Hivid

CConrado Roberto Hoffmann Filho

Preclinical

6 9

Aurlumyn

BBTG International Inc.

Preclinical

1 10

Intuniv

PPromius Pharma, LLC

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

Phase 1/2Not yet recruiting

Injury

NCT07454421

Clinical

Trials by Indication[1]

Diarrhea5 trials

Anti-Secretory Drug in Treatment of Acute Watery Diarrhea

Completed·—·Phase 1·NCT05216822·50 enrolled

Efficacy of Racecadotril in Acute Watery Diarrhea in Children

Completed·CCentro Pediatrico Albina de Patino·Phase 4·NCT01577043·52 enrolled

Safety and Efficacy of Racecadotril in Children With Acute Watery Diarrhea

Completed·—·N/A·NCT07392931·200 enrolled

Show 2 more trials

Bioequivalence Between a Racecadotril Capsule and Film-Coated Tablet (FCT) to Treat Diarrhea in Adults

Completed·MMcNeil AB·Phase 1·NCT01302093·40 enrolled

Comparing the Efficacy of Anti-secretory Versus Oral Immunoglobulins for Reducing the Episodes of Diarrhea in Children

Unknown status·SShaheed Zulfiqar Ali Bhutto Medical University·N/A·NCT04885049·60 enrolled

Injury1 trial

Racecadotril for Organ Injury in Sepsis Patients

Not yet recruiting·ZZhujiang Hospital·Phase 1/2·NCT07454421·44 enrolled

Acute Diarrhea1 trial

Safety, Efficacy and Cost-effectiveness of Racecadotril in Children With Acute Diarrhea in Mexico

Completed·NNational Institute of Pediatrics, Mexico·Phase 3·NCT01153854·454 enrolled

Tics1 trial

Study to Compare the Pharmacokinetics Profiles of Four Racecadotril Products

Completed·MMcNeil AB·Phase 1·NCT01476683·24 enrolled

MPA1 trial

Racecadotril Suspension Linearity Study & Comparative Bioavailability Versus Granules

Completed·BBioprojet·Phase 1·NCT01948011·53 enrolled

2 more indications

Fasting Conditions1 trial

Bioequivalence Study of Generic Racecadotril 100 mg Capsules Under Fasting Conditions

Unknown status·PPharma Nueva·Phase 1·NCT06297174·44 enrolled

Diarrhoea1 trial

Efficacy of Racecadotril in Addition to Standard Treatment in Decreasing the Duration of Acute Diarrhea in Children as Compared to Standard of Treatment Alone

Completed·LLiaquat National Hospital & Medical College·Preclinical·NCT06529497·260 enrolled

Sources

References

[1]
ClinicalTrials.gov — 11 trial records for Racecadotril. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Racecadotril compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Racecadotril. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — McNeil AB company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: MMcNeil AB

Racecadotril

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2027

Trials by Indication[1]

Diarrhea5 trials

Injury1 trial

Acute Diarrhea1 trial

Tics1 trial

MPA1 trial

Fasting Conditions1 trial

Diarrhoea1 trial

References

Drug Info

Quick Facts

Related News